Among patients without diabetes, the fasting plasma GLP-1 levels in CAD patients are significantly lower than in non-CAD patients (3.2 [2.6–3.7] versus 3.9 [3.0–5.2] pM, P < 0.001) [60]. Here, GLP1R is linked to diabetes mellitus.